DOI:
10.1055/s-00000007
Aktuelle Urologie
LinksClose Window
References
Bergmann L. et al.
A Prospective Randomized Phase-II Trial with Temsirolimus vs. Sunitinib in non-clear Renal Cell Carcinoma. A Study of the CESAR Central European Society for Anticancer Drug Research-EWIV and Interdisciplinary Renal Cell Carcinoma Group of the German Cancer Society (IAGN).
ECCO. 2015 abstract #2617
Access:
We do not assume any responsibility for the contents of the web pages of other providers.